ADVM
Price
$2.32
Change
-$0.17 (-6.83%)
Updated
Jun 27 closing price
Capitalization
48.47M
KURA
Price
$5.67
Change
-$0.06 (-1.05%)
Updated
Jun 27 closing price
Capitalization
490.88M
33 days until earnings call
Interact to see
Advertisement

ADVM vs KURA

Header iconADVM vs KURA Comparison
Open Charts ADVM vs KURABanner chart's image
Adverum Biotechnologies
Price$2.32
Change-$0.17 (-6.83%)
Volume$2.8M
Capitalization48.47M
Kura Oncology
Price$5.67
Change-$0.06 (-1.05%)
Volume$3.33M
Capitalization490.88M
ADVM vs KURA Comparison Chart in %
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. KURA commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a StrongBuy and KURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ADVM: $2.32 vs. KURA: $5.67)
Brand notoriety: ADVM and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 524% vs. KURA: 209%
Market capitalization -- ADVM: $48.47M vs. KURA: $490.88M
ADVM [@Biotechnology] is valued at $48.47M. KURA’s [@Biotechnology] market capitalization is $490.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADVM and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 4 TA indicator(s) are bullish while KURA’s TA Score has 3 bullish TA indicator(s).

  • ADVM’s TA Score: 4 bullish, 4 bearish.
  • KURA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ADVM is a better buy in the short-term than KURA.

Price Growth

ADVM (@Biotechnology) experienced а +3.11% price change this week, while KURA (@Biotechnology) price change was -3.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

ADVM is expected to report earnings on Apr 15, 2025.

KURA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KURA($491M) has a higher market cap than ADVM($48.5M). KURA YTD gains are higher at: -34.902 vs. ADVM (-50.321). ADVM has higher annual earnings (EBITDA): -154.84M vs. KURA (-177.18M). KURA has more cash in the bank: 658M vs. ADVM (83.1M). KURA has less debt than ADVM: KURA (19.4M) vs ADVM (93.2M). KURA has higher revenues than ADVM: KURA (68M) vs ADVM (1M).
ADVMKURAADVM / KURA
Capitalization48.5M491M10%
EBITDA-154.84M-177.18M87%
Gain YTD-50.321-34.902144%
P/E RatioN/AN/A-
Revenue1M68M1%
Total Cash83.1M658M13%
Total Debt93.2M19.4M480%
FUNDAMENTALS RATINGS
ADVM vs KURA: Fundamental Ratings
ADVM
KURA
OUTLOOK RATING
1..100
6167
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KURA's Valuation (24) in the Biotechnology industry is in the same range as ADVM (38). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

KURA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ADVM (100). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

KURA's SMR Rating (96) in the Biotechnology industry is in the same range as ADVM (99). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

KURA's Price Growth Rating (65) in the Biotechnology industry is in the same range as ADVM (65). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

KURA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ADVM (100). This means that KURA’s stock grew similarly to ADVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADVMKURA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BWLCX22.430.07
+0.31%
American Beacon Man Lg Cp Value C
MEMFX34.53N/A
N/A
MFS Emerging Markets Equity R2
WIMVX11.87N/A
N/A
Segall Bryant & Hamill Glb All Cp Inst
NRERX13.63N/A
N/A
Neuberger Berman Real Estate R3
LAVTX15.83N/A
N/A
Lord Abbett Fundamental Equity R5

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with CCCC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-6.83%
CCCC - ADVM
47%
Loosely correlated
-6.59%
IMNM - ADVM
47%
Loosely correlated
-0.11%
ATXS - ADVM
45%
Loosely correlated
+2.94%
OCUL - ADVM
44%
Loosely correlated
-2.43%
XENE - ADVM
44%
Loosely correlated
+0.65%
More

KURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KURA has been loosely correlated with PYXS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if KURA jumps, then PYXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KURA
1D Price
Change %
KURA100%
-1.05%
PYXS - KURA
66%
Loosely correlated
-5.08%
ZYME - KURA
44%
Loosely correlated
+0.73%
KYMR - KURA
44%
Loosely correlated
-3.48%
ADVM - KURA
43%
Loosely correlated
-6.83%
AXON - KURA
41%
Loosely correlated
+1.82%
More